BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34182223)

  • 1. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
    Dahlstrom KR; Anderson KS; Guo M; Kwon MC; Messick CA; Pettaway CA; Asomaning N; Hopper M; Price A; Xu L; Day AT; Gillenwater AM; Sturgis EM
    Oral Oncol; 2021 Sep; 120():105397. PubMed ID: 34182223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
    Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
    D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
    Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.
    Dang J; Feng Q; Eaton KD; Jang H; Kiviat NB
    BMC Oral Health; 2015 Oct; 15(1):126. PubMed ID: 26472641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
    Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
    Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Oral HPV16 and HPV18 Detection in Persons Attending Dental Clinics.
    Stankiewicz Karita HC; Magaret A; Huang ML; Jerome KR; Feng Q; Wald A
    Sex Transm Dis; 2020 Feb; 47(2):100-104. PubMed ID: 31804297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.
    D'Souza G; Gross ND; Pai SI; Haddad R; Anderson KS; Rajan S; Gerber J; Gillison ML; Posner MR
    J Clin Oncol; 2014 Aug; 32(23):2408-15. PubMed ID: 24778397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus detection in oropharyngeal cancers: Comparison of saliva sampling methods.
    Tang KD; Kenny L; Frazer IH; Punyadeera C
    Head Neck; 2019 May; 41(5):1484-1489. PubMed ID: 30582230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study.
    Dickey BL; Giuliano AR; Sirak B; Abrahamsen M; Lazcano-Ponce E; Villa LL; Coghill AE
    J Infect Dis; 2023 Jan; 227(2):256-260. PubMed ID: 35679351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
    Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M
    Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.
    Agrawal Y; Koch WM; Xiao W; Westra WH; Trivett AL; Symer DE; Gillison ML
    Clin Cancer Res; 2008 Nov; 14(21):7143-50. PubMed ID: 18981014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Mattox AK; D'Souza G; Khan Z; Allen H; Henson S; Seiwert TY; Koch W; Pardoll DM; Fakhry C
    Oral Oncol; 2022 May; 128():105805. PubMed ID: 35334415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
    Kreimer AR; Pierce Campbell CM; Lin HY; Fulp W; Papenfuss MR; Abrahamsen M; Hildesheim A; Villa LL; Salmerón JJ; Lazcano-Ponce E; Giuliano AR
    Lancet; 2013 Sep; 382(9895):877-87. PubMed ID: 23827089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.
    Pierce Campbell CM; Kreimer AR; Lin HY; Fulp W; O'Keefe MT; Ingles DJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Giuliano AR
    Cancer Prev Res (Phila); 2015 Mar; 8(3):190-6. PubMed ID: 25575501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Human Papillomavirus in Penile Carcinomas Worldwide.
    Alemany L; Cubilla A; Halec G; Kasamatsu E; Quirós B; Masferrer E; Tous S; Lloveras B; Hernández-Suarez G; Lonsdale R; Tinoco L; Alejo M; Alvarado-Cabrero I; Laco J; Guimerà N; Poblet E; Lombardi LE; Bergeron C; Clavero O; Shin HR; Ferrera A; Felix A; Germar J; Mandys V; Clavel C; Tzardi M; Pons LE; Wain V; Cruz E; Molina C; Mota JD; Jach R; Velasco J; Carrilho C; López-Revilla R; Goodman MT; Quint WG; Castellsagué X; Bravo I; Pawlita M; Muñoz N; Bosch FX; de Sanjosé S;
    Eur Urol; 2016 May; 69(5):953-61. PubMed ID: 26762611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.
    Beachler DC; Pinto LA; Kemp TJ; Nyitray AG; Hildesheim A; Viscidi R; Schussler J; Kreimer AR; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):496-502. PubMed ID: 29475967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.